Publications
Detailed Information
Effect of dutasteride on the expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and microvessel density in rat and human prostate tissue
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ku, Ja Hyeon | - |
dc.contributor.author | Shin, Jung Ki | - |
dc.contributor.author | Cho, Min Chul | - |
dc.contributor.author | Myung, Jae Kyung | - |
dc.contributor.author | Paick, Jae-Seung | - |
dc.contributor.author | Moon, Kyung Chul | - |
dc.date.accessioned | 2012-06-04T00:57:30Z | - |
dc.date.available | 2012-06-04T00:57:30Z | - |
dc.date.issued | 2009 | - |
dc.identifier.citation | SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY; Vol.43 6; 445-453 | ko_KR |
dc.identifier.issn | 0036-5599 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76742 | - |
dc.description.abstract | Objective. To evaluate the effects of dutasteride on the expression of angiogenesis markers in rat and human prostates. Material and methods. Eight-week-old male Sprague-Dawley rats were divided into three groups of six each according to dutasteride dose, including the control group (regular diet), 2.5 mg group (2.5 mg/kg dutasteride) and 5.0 mg group (5.0 mg/kg dutasteride). A total of 41 patients awaiting transurethral resection of the prostate (TURP) were divided into two groups: 20 patients received no medication and 21 received 0.5 mg dutasteride daily for 2-4 weeks until TURP. Results. At 2 weeks, dutasteride effected a significant decrease in body weight and prostate weight compared with the control rat group. Analysis by reverse transcription-polymerase chain reaction and Western blot revealed that hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor (VEGF) expression was lower in the dutasteride-treated groups than in the control group, except for HIF-1 alpha protein. HIF-1 alpha and VEGF expression was similar in the 2.5 mg and 5.0 mg groups. Human prostate tissues demonstrated homogeneous staining of HIF-1 alpha and VEGF with regard to extent, intensity and intracellular location in both groups. There was no significant difference in microvessel density between the two groups. Conclusions. The expression of HIF-1 alpha and VEGF in rat prostates is suppressed by dutasteride. However, less than 4 weeks of dutasteride administration does not suppress the expression of HIF-1 alpha, VEGF and microvessel density in human prostate tissue. Further clinical investigation with dutasteride including a larger, placebo-controlled study is warranted to establish the mechanism and duration of dutasteride. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | TAYLOR & FRANCIS AS | ko_KR |
dc.subject | Dutasteride | ko_KR |
dc.subject | vascularity | ko_KR |
dc.subject | vascular endothelial growth factor | ko_KR |
dc.subject | hypoxia-inducible factor | ko_KR |
dc.subject | prostate | ko_KR |
dc.title | Effect of dutasteride on the expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and microvessel density in rat and human prostate tissue | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 구자현 | - |
dc.contributor.AlternativeAuthor | 신정기 | - |
dc.contributor.AlternativeAuthor | 조민철 | - |
dc.contributor.AlternativeAuthor | 명재경 | - |
dc.contributor.AlternativeAuthor | 문경철 | - |
dc.contributor.AlternativeAuthor | 백재승 | - |
dc.identifier.doi | 10.3109/00365590903337896 | - |
dc.citation.journaltitle | SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY | - |
dc.description.citedreference | Hahn RG, 2007, BJU INT, V99, P587, DOI 10.1111/j.1464-410X.2006.06619.x | - |
dc.description.citedreference | Lekas AG, 2006, UROLOGY, V68, P436, DOI 10.1016/j.urology.2006.03.038 | - |
dc.description.citedreference | Donohue JF, 2005, BJU INT, V96, P1319, DOI 10.1111/j.1464-410X.2005.05849.x | - |
dc.description.citedreference | Boccon-Gibod L, 2005, PROG UROL, V15, P1085 | - |
dc.description.citedreference | Ozdal OL, 2005, PROSTATE CANCER P D, V8, P215, DOI 10.1038/sj.pcan.4500818 | - |
dc.description.citedreference | Lund L, 2005, SCAND J UROL NEPHROL, V39, P160, DOI 10.1080/00365590510007694 | - |
dc.description.citedreference | Crea G, 2005, UROL INT, V74, P51, DOI 10.1159/000082709 | - |
dc.description.citedreference | Andriole GL, 2004, J UROLOGY, V172, P915, DOI 10.1097/01.ju.0000136430.37245.b9 | - |
dc.description.citedreference | Park JW, 2004, J PHARMACOL SCI, V94, P221 | - |
dc.description.citedreference | Du ZX, 2003, CHINESE MED J-PEKING, V116, P1936 | - |
dc.description.citedreference | Pareek G, 2003, J UROLOGY, V169, P20, DOI 10.1097/01.ju.0000039923.75777.91 | - |
dc.description.citedreference | Donohue JF, 2002, J UROLOGY, V168, P2024, DOI 10.1097/01.ju.0000028607.29093.56 | - |
dc.description.citedreference | Kearney MC, 2002, J UROLOGY, V167, P2489 | - |
dc.description.citedreference | Haggstrom S, 2002, SCAND J UROL NEPHROL, V36, P182 | - |
dc.description.citedreference | Hochberg DA, 2002, J UROLOGY, V167, P1731 | - |
dc.description.citedreference | Sandfeldt L, 2001, UROLOGY, V58, P972 | - |
dc.description.citedreference | Talks KL, 2000, AM J PATHOL, V157, P411 | - |
dc.description.citedreference | Burchardt M, 2000, PROSTATE, V43, P184 | - |
dc.description.citedreference | Hagerty JA, 2000, UROLOGY, V55, P684 | - |
dc.description.citedreference | Lekas E, 2000, BJU INT, V85, P962 | - |
dc.description.citedreference | Foley SJ, 2000, J UROLOGY, V163, P496 | - |
dc.description.citedreference | Levine AC, 1998, ENDOCRINOLOGY, V139, P4672 | - |
dc.description.citedreference | Sieber PR, 1998, J UROLOGY, V159, P1232 | - |
dc.description.citedreference | Kashif KM, 1998, PROSTATE CANCER P D, V1, P154 | - |
dc.description.citedreference | Franck-Lissbrant I, 1998, ENDOCRINOLOGY, V139, P451 | - |
dc.description.citedreference | Miller MI, 1998, UROLOGY, V51, P237 | - |
dc.description.citedreference | Lekas E, 1997, UROL RES, V25, P309 | - |
dc.description.citedreference | Carlin BI, 1997, PROSTATE, V31, P180 | - |
dc.description.citedreference | PUCHNER PJ, 1995, J UROLOGY, V154, P1779 | - |
dc.description.citedreference | MCCONNELL JD, 1992, J CLIN ENDOCR METAB, V74, P505 | - |
dc.description.tc | 1 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.